Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its quarter ended March 31, 2024. Financial highlights for the three months ended March 31, 2024 and the same period in 2023 include: Total revenue of $957,447 compared to $ 596,455, an increase of 60.5% Gross Margin of $743,719 compared to...Read More